Picture of Arno Therapeutics logo

ARNI Arno Therapeutics Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for Arno Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2011
December 31st
2012
December 31st
2013
December 31st
2014
December 31st
2015
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-7.91-14.4-39.77.77-11.5
Depreciation
Non-Cash Items1.14.1824.6-24.71.55
Unusual Items
Other Non-Cash Items
Changes in Working Capital-0.0390.7770.781-1.92-0.02
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-6.83-9.42-14.2-18.8-9.97
Capital Expenditures-0.02300-0.020
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items000-0
Other Investing Cash Flow
Cash from Investing Activities-0.02300-0.020
Financing Cash Flow Items0-1.170
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities0.00613.730.102.08
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-6.854.2715.8-18.8-7.88